Pages
News and insights
- Full year results 2024: portfolio makes good progress in challenging conditions
- Watch: Frontier CEO Neil Crabb on full year results, portfolio progress and our fundraising
- Watch: The Vaccine Group CEO Dr Jeremy Salt on £400,000 Innovate UK grant for animal health
- TVG collaboration with UK government agency awarded £400,000 by Innovate UK
- Watch: DeakinBio chief executive Dr Aled Roberts discuss the company’s innovative bio-materials
- DeakinBio raises £693,000 to scale up sustainable alternatives to ceramics
- Watch: TVG CEO Jeremy Salt on how Defra grant will help to tackle zoonotic pig disease
- TVG led project to tackle zoonotic pig disease after winning £1m UK government grant
- Nesta invests in Nandi Proteins
- Watch Pulsiv Chief Product Officer Dr Tim Moore discuss the potential for the company’s groundbreaking technology
- Pulsiv launches world’s most efficient 65W USB-C charger reference design
- Watch GraphEnergyTech CEO Thomas Baumeler discuss the potential of graphene electrodes
- Aramco Ventures backs GraphEnergyTech as part of £1 million fundraising
- Cambridge Raman Imaging launches pre-Series A funding round
- Alusid makes tile from 100 per cent recycled content in “probable” world first
- Cambridge Raman Image to accelerate growth with working capital facility
- Alusid launches first floor tile through Topps Group’s Parkside Architectural Tiles
- The Vaccine Group and The Pirbright Institute collaborate against African swine fever
- Frontier IP announces stake in Diagen Ai and TVG collaboration
- Jo Stent joins as Chief Financial Officer
- Elute Intelligence appoints Steve Cable as CEO
- Half year results: maturing portfolio makes good commercial and technical progress
- Alusid outlines plans for 2024 after raising £1.1 million
- Octopus backs Alusid as part of £1.1 million fundraising
- Horns of plenty: unicorns, narwhals and the changing company valuation landscape
- The Vaccine Group appoints industry experts to new Advisory Board
- Full year results 2023: good technical and commercial progress in challenging markets
- Dame Julia King, Baroness Brown of Cambridge, to become Frontier IP Chair
- Bio-materials developer DeakinBio joins our portfolio
- Exscientia’s new AI drug discovery collaboration with Merck worth up to $674 million
- Mark Gerhard, technology pioneer and serial entrepreneur, joins Pulsiv as Chairman
- Fieldwork Robotics raises £1.5 million and appoints new CEO
- Emporia4KT reaches concludes successfully
- Topps Tiles launches Alusid-made wall tiles
- Nigel Grierson and Dr David Holbrook join the Frontier IP board of directors
- Half year results: portfolio makes significant commercial and technical progress
- Alusid extends product range in collaboration with world leader Imerys
- Celerum appoints Chief Executive Officer
- DARPA-funded TVG project develops transmissible Lassa fever vaccine candidate
- TVG successfully completes Anglo-Chinese pig vaccine project
- Pulsiv raises £1.5 million in equity funding round
- Final results: portfolio equity value up 24 per cent to £39.7 million
- Pulsiv unveils world-leading electronics technology to cut energy consumption
- Sir Michael Rake to join CamGraPhIC board as company raises £1.26 million
- Cambridge Raman Imaging raises £1.1 million to accelerate scale up
- Robot-picked raspberries, COVID-19 vaccines, Portugal and graphene: read our newsletter
- Beyond Venture Funding: join our event with Williams Advanced Engineering on 17 May
- Half year results: pre-tax profits rise by 239 per cent to £10.3 million
- Frontier IP raises further £3.2 million after selling more Exscientia shares
- Cambridge Raman Imaging gains grant to transform cancer diagnosis and treatment
- Frontier IP sells part of stake in Exscientia
- Frontier IP: anticipates first half results ahead of management expectations
- Celerum launches first product using AI to improve logistics
- TVG next-generation COVID-19 vaccine achieves significant milestone
- “For us, it is fantastic when you see a product getting deployed or out there.”
- Chief Executive Neil Crabb on our final results
- Baroness Brown, chair of The Carbon Trust, joins Frontier IP board
- Final results: pre-tax profit up 145 per cent to £10.2 million
- Frontier IP and the UN Sustainable Development Goals: our latest newsletter
- Exscientia valued at $2.9 billion as it lists on Nasdaq
- CamGraPhIC raises £1.6 million for high-speed, low-energy graphene photonics
- Exscientia files for IPO in the United States
- Bill & Melinda Gates Foundation in $70 million collaboration with Exscientia
- How AquaInSilico aims to help Cape Verde with water scarcity and marine conservation
- Adam Westcott to join Pulsiv as Chief Financial Officer
- David Flower joins Nandi Proteins as Chief Executive Officer
- Next steps for Pulsiv, a first for Alusid and more in our latest newsletter
- Pulsiv appoints Darrel Kingham as CEO and completes £1.5 million fundraising
- Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb
- The Vaccine Group appoints Jeremy Salt as Chief Executive Officer
- Frontier IP: full year outcome “materially ahead of management expectations”
- Exscientia announces investment of up to $525m led by SoftBank
- Emporia4KT launches technology transfer training programme
- Frontier IP looks to the future with confidence
- Fieldwork Robotics raises £675,000 to accelerate development of harvesting robots
- Chief Executive Neil Crabb: talking tech transfer with the Global University Venturing podcast
- Portugal Ventures backs inSignals Neurotech with €100,000 investment
- AquaInSilico to receive $250,000 through UN Development Programme to help protect one of world’s most diverse marine environments
- BlackRock funds back $100 million Exscientia Series C financing round
- Pulsiv Solar raises £890,000 to accelerate development of patented power conversion technology
- Catch up on recent developments at Frontier IP in our latest quarterly newsletter
- Frontier supports technology to eradicate detectable TCA from natural cork stoppers
- Learn how Elute Intelligence can make your FTO searches faster and easier
- Frontier IP appoints Director of Corporate Relationships to support portfolio fundraisings
- Elute Intelligence raises £250,000 in first equity fund raising
- Cambridge Raman Imaging is part of EUR5m project to develop groundbreaking medical imaging technology
- Fieldwork Robotics to develop robot simulator after winning grant from Innovate UK’s Sustainable Innovation Fund
- Investor presentation for Full Year Results to 30 June 2020 and VSA Capital buy note available now
- Alusid raises £250,000 including £125,000 from UK government’s Future Fund
- Find out what’s been happening at Frontier IP and the portfolio in our new quarterly newsletter
- The Vaccine Group to collaborate with The Pirbright Institute and ECO Animal Health Group
- Bonduelle Group enters collaboration with Fieldwork Robotics to develop cauliflower harvesting robot
- UK government’s Future Fund invests £360,000 in Nandi Proteins as part of £720,000 fund raising
- Innovate UK extends backing for Fieldwork Robotics
- Frontier IP strengthens team with appointment of Software Commercialisation Director
- Elute Intelligence launches ground breaking Patent Reader commercially
- UK government Future Fund invests £250,000 in Pulsiv Solar
- Cambridge Raman Imaging completes £250,000 funding round to commercialise novel medical microscope technology
- AquaInSilico to commercialise wastewater treatment software following grant award
- Strong commercial and technical progress for Pulsiv Solar
- Bosch to work with Fieldwork Robotics to optimise agricultural robots
- The Vaccine Group makes significant progress with COVID-19 animal vaccines
- University of Cambridge and Frontier IP collaboration to tackle gum disease wins grant funding
- Exscientia raises $60 million in Series C financing round led by Novo Holdings
- Molendotech raises £425,000 to accelerate development of novel rapid tests for harmful bacteria
- Alusid can now make 1,000m2 a day on industry-standard manufacturing equipment
- Step change for battery charger efficiency
- Pulsiv Solar shows strong progress in developing battery charger technology and gains new patent
- Alusid launches luxury Block range through Kickstarter campaign
- Exscientia announces joint initiave to identify COVID-19 drugs with Diamond Light Source and Scripps Research
- Frontier IP ‘in strong position’ and working closely with portfolio companies to mitigate new risks
- The Vaccine Group starts work on COVID-19 animal vaccine
- Strong interims and handling the COVID-19 risk
- The Vaccine Group starts work on COVID-19 animal vaccine, makes strong progress with technology
- The Vaccine Group video to The Vaccine Group starts work on COVID-19 animal vaccine
- Elute Intelligence supports scientists researching COVID-19
- Frontier IP Group’s Neil Crabb reports back on ‘solid’ portfolio growth and developments
- Cambridge Raman Imaging wins €140,000 EU Graphene Flagship funding
- Frontier IP raises stake in Celerum to 33.8 per cent
- Exscientia: worlds first trials of new drug candidate created by artificial intelligence
- The Vaccine Group raises £680,000 through initial equity fund raise
- Fieldwork raises £298,000 in first equity funding round
- Bayer and Exscientia collaborate to use AI in cardiovascular and oncology drug discovery
- Amprologix wins £1.2 million Department of Health and Social Care SBRI funding
- Elute Intelligence Holdings joins Frontier IP portfolio
- Innovate UK grant for Pulsiv Solar to step up development of energy-efficient solar power technology
- Fieldwork completes initial field trials of raspberry harvesting robot system
- Bosch UK to work with Pulsiv Solar to optimise energy efficient solar power technology
- Parkside Architectural Tiles launches exclusive Alusid sustainable tile range
- Fieldwork Robotics wins £547,250 Innovate UK ISCF grant to accelerate robot development
- Nandi Proteins-led consortium wins joint Coeliac UK and Innovate UK grant to improve the quality of gluten-free bread
- The Vaccine Group wins grant from Department of Health and Social Care
- Palintest starts commercial roll out of Molendotech bathing water quality test SirenBW
- Molendotech signs collaboration agreement with leading European fresh produce company G’s Group
- Amprologix to develop new antibiotics in partnership with Ingenza
- Alusid raises £1.34 million to scale up manufacturing
- Nandi raises £1 million
- Tarsis Technology Collaboration with World-leading Crop-Protection Company
Portfolio
- DeakinBio
- GraphEnergyTech
- AquaInSilico
- Elute Intelligence
- Insignals Neurotech
- Des Solutio
- Celerum
- CamGraphIC
- Cambridge Raman Imaging
- Alusid
- Nandi Proteins
- The Vaccine Group
- PoreXpert
- Pulsiv
- Exscientia
- Molendotech
- Fieldwork Robotics
- Amprologix
